Healthcare & Life Sciences
DeuterOncology
Belgiumdeuteroncology.com
DeuterOncology is a Healthcare & Life Sciences startup based in Belgium, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About DeuterOncology
DeuterOncology is a startup based in Belgium. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
DeuterOncology is developing deuterated MET kinase inhibitors, primarily DO-2 and its active metabolite DO-5, targeting MET exon 14 skipping mutations and MET amplification in non-small cell lung cancer (NSCLC) and other EGFR-driven cancers.
Explore DeuterOncology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.